The GTE cohort study reported that 4.8% of MEN1 patients had histologically proven LNETs while the DMSG identified radiologically suspicious lung lesions in approximately 23% of an MEN1 cohort followed for a median of 6.6 years [11,12]. The gene discussed is MEN1; the disease is multiple endocrine neoplasia type 1.